Determination of acepromazine, ketamine, medetomidine, and xylazine in serum: Multi-residue screening by liquid chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 29, Issue 6, 2005, Pages 544-551

  Miksa, Irina Rudik ^a   Cummings, Margaret R ^a   Poppenga, Robert H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; KETAMINE; MEDETOMIDINE; XYLAZINE;

ACCURACY; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; COW; DOG; DRUG DETERMINATION; DRUG SCREENING; HORSE; ION MONITORING; LINEAR SYSTEM; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SERUM;

ANIMALIA; BOVINAE; CANIS FAMILIARIS; EQUIDAE; EQUUS CABALLUS;

EID: 27744507037     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/29.6.544     Document Type: Article

References (55)

1. M.D. Sinclair. A review of the physiological effects of alpha-2-agonists related to the clinical use of medetomidine in small animal practice. Can. Vet. J. 44: 885-897 (2003).
2. S.B.R. Kastner, P. Wapf, K. Feige, D. Demuth, R. Bettschart- Wolfensberger, M.K. Akens, and M. Huhtinen. Pharmacokinetics and sedative effects of intramuscular medetomidine in domestic sheep. J. Vet. Pharmacol. Ther. 26: 271-276 (2003).
3. B. Ranheim, J.M. Arnemo, K.A. Ryeng, N.E. Soli, and T.E. Horsberg. A pharmacokinetic study including some relevant clinical effects of medetomidine and atipamezole in lactating dairy cows. J. Vet. Pharmacol. Ther. 22: 368-373 (1999).
4. A.G. Gallanosa, D.A. Spyker, J.R. Shipe, and D.L. Morris. Human xylazine overdose: a comparative review with clonidine, phenothiozines, and tricyclic antidepressants. Clin. Toxicol. 18: 663-678 (1981).
5. A. Poklis, M.A. Mackell, and M.E. Case. Xylazine in human tissue and fluids in a case of fatal drug abuse. J. Anal. Toxicol. 9: 234-236 (1985).
6. D.G. Spoerke, A.H. Hall, M.J. Grimes, and B.N. Honea. Human overdose with the veterinary tranquilizer xylazine. Am. J. Emerg. Med. 4: 222-224 (1986).
7. R.E. Mittleman, W.L. Hearn, and G.W. Hime. Xylazine toxicity: literature review and report of two cases. J. Forensic Sci. 43: 400-402 (1998).
8. U. Hoffmann, C.M. Meister, K. Golle, and M. Zschiesche. Severe intoxication with the veterinary tranquilizer xylazine in humans. J. Anal. Toxicol. 25: 245-249 (2001).
9. K.A. Moore, M.G. Ripple, S. Sakinedzad, B. Levine, and D.R. Fowler. Tissue distribution of xylazine in a suicide by hanging. J. Anal. Toxicol. 27: 110-112 (2003).
10. M.E. Stillwell. A reported case involving impaired driving following self-administration of xylazine. Forensic Sci. Int. 134: 25-28 (2003).
11. D.C. Plumb. Veterinary Drug Handbook, 4th ed. Iowa State Press, Ames, IA, 2002.
12. L.C. Williams and C. Keyes. Psychoactive Drugs. In Clinical Toxicology, 1st ed., M.D. Ford, K.A. Delaney, L.J. Ling, and T. Erickson, Eds. W.B. Saunders Company, Philadelphia, PA, 2001, pp 640-649.
13. A.J. Giannini, N.A. Underwood, and M. Condon. Acute ketamine intoxication treated by haloperidol: a preliminary study. Am. J. Ther. 7: 389-391 (2000).
14. J.R. Gill and M. Stajic. Ketamine in non-hospital and hospital deaths in New York City. J. Forensic Sci. 45: 655-658 (2000).
15. G.K. McEvoy, Ed. AHFS Drug Information. American Society of Health-System Pharmacists, Inc., Bethesda, MD, 2002.
16. R.E. Clutton. Attempted suicide with acepromazine maleate: a case report. Vet. Hum. Toxicol. 27: 391 (1985).
17. S.D. Berns and J.L. Wright. Pediatric acepromazine poisoning: the importance of child-resistant packaging for veterinary drugs. Am. J. Emerg. Med. 11: 247-248 (1993).
18. L.I. Stowell. Suicide with the veterinary drug acepromazine. J. Anal. Toxicol. 22: 166-168 (1998).
19. C.M. Moore and J.S. Oliver. Rapid extraction and determination of xylazine in greyhound urine using high-performance liquid chromatography. J. Chromatogr. 491: 519-524 (1989).
20. A. Akbari, B.J. Gordon, P.B. Bush, and J.N. Moore. Determination of xylazine in blood components using high-performance liquid chromatography. J. Chromatogr. 426: 207-211 (1988).
21. J.E. Psomas and D.J. Fletouris. Liquid chromatography assay of xylazine in sheep and cattle plasma. J. Liq. Chomatogr. 15: 1543-1551 (1992).
22. T. McDonnell, M.T. Kelly, and M.R. Smyth. HPLC determination of xylazine in equine plasma by high performance liquid chromatography. Anal. Lett. 26: 1547-1556 (1993).
23. D. Bohm, R. Goebel, A. Lippert, D. Tesch, and K. Lusky. Analysis of xylazine residues by gas chromatography/mass spectrometry. Bioforum 15: 212-214 (1992).
24. L. Vuorilehto, J.S. Salonen, and M. Anttila. Picogram level determination of medetomidine in dog serum by capillary gas chromatography with negative ion chemical ionization mass spectrometry. J. Chromatogr. 497: 282-287 (1989).
25. Y.A. Blednov and V.J. Simpson. Gas chromatography-mass spectrometry assay for determination of ketamine in brain. J. Pharmacol. Toxicol. Methods 41: 91-95 (1999).
26. J.-L. Zhang. Improved HPLC assay for determination of ketamine in human plasma. Zhongguo Yiyuan Yaoxue Zazhi 20: 11-12 (2000).
27. S. Kwiatkowski, L. Sturma, M.R. Dai, H.H. Tai, D.S. Watt, C.L. Tai, W.E. Woods, T.J. Weckman, J.M. Yang, et al. Immunoassay detection of drugs in racing horses. VII. Detection of acepromazine in equine urine and blood by ELISA and PCFIA. Res. Commun. Chem. Path. Pharmacol. 61: 391-412 (1988).
28. D.C. Holland, R.K. Munns, J.E. Roybal, J.A. Hurlbut, and A.R. Long. Simultaneous determination of xylazine and its major metabolite, 2,6-dimethylaniline, in bovine and swine kidney by liquid chromatography. J. AOAC Int. 76: 720-724 (1993).
29. M.-H. Spyridaki, E. Lyrus, I. Georgoulakis, D. Kouretas, M. Konstantinidou, and C.G. Georgakopoulos. Determination of xylazine and its metabolites by GC-MS in equine urine for doping analysis. J. Pharmacol. Biomed. Anal. 35: 107-116 (2004).
30. L.A. Van Ginkel, P.L. Schwillens, and M. Olling. Liquid chromatography method with on-line UV spectrum identification and offline thin-layer chromatographic confirmation for the detection of tranquilizers and carazolol in pig kidneys. Anal. Chim. Acta 225: 137-146 (1989).
31. M.C. Quintana, M.H. Blanco, J. Lacal, and L. Hernandez. Analysis of pharmaceutical residues in bovine liver by HPLC. J. Liq. Chromatogr. Related Technol. 24: 735-745 (2001).
32. H.J. Keukens and M.M. Aerts. Determination of residues of carazolol and a number of tranquilizers in swine kidney by high-performance liquid chromatography with ultraviolet and fluorescence detection. J. Chromatogr. A 464: 149-161 (1989).
33. M.D. Rose and G. Shearer. Determination of tranquilizers and carazolol residues in animal tissue using high-performance liquid chromatography with electrochemical detection. J. Chromatogr. A 624: 471-477 (1992).
34. Y. Govaert, P. Batjoens, K. Tsilikas, J.M. Degroodt, and S. Srebrnik. Multi-residue analysis of tranquillizers in meat: confirmatory assays using mass spectrometry. Analyst 123: 2507-2512 (1998).
35. A. Kaufmann and B. Ryser. Multiresidue analysis of tranquilizers and the beta-blocker carazolol in meat by liquid chromatrography/tandem mass spectrometry. Rapid Comm. Mass Spectrom. 15: 1747-1751 (2001).
36. P. Delahaut, C. Levaux, P. Eloy, and M. Dubois. Validation of a method for detecting and quantifying tranquillizers and a beta-blocker in pig tissues by liquid chromatography-tandem mass spectrometry. Anal. Chim. Acta 482: 335-340 (2003).
37. F. Liu, X. Hu, and Q. Li. Quantitative analysis of ketamine and xylazine in plasma and brain homogenates of rats by GC-MS. Fenxi Ceshi Xuebao 12: 26-30 (1993).
38. M.-L. Olmos-Carmona and M. Hernandez-Carrasquilla. Gas chromatographic-mass spectrometric analysis of veterinary tranquillizers in urine: evaluation of method performance. J. Chromatogr. B 734: 113-120 (1999).
39. F. Niedorf, H.-H. Bohr, and M. Kietzmann. Simultaneous determination of ketamine and xylazine in canine plasma by liquid chromatography with ultraviolet absorbance detection. J. Chromatogr. B 791: 421-426 (2003).
40. S. Gentili, M. Cornetta, and T. Macchia. Rapid screening procedure based on headspace solid-phase microextraction and gas chromatography-mass spectrometry for the detection of many recreational drugs in hair. J. Chromatogr. B 801: 289-296 (2004).
41. D. Zhang and Y. Jiang. Simultaneous determination of ketamine, phenobarbitone, and atropine in plasma by RP-HPLC. Zhongguo Yiyuan Yaoxue Zazhi 17: 101-103 (1997).
42. H.Z. Rofael and M.S. Abdel-Rahman. Development and validation of a high-performance liquid chromatography method for the determination of cocaine, its metabolites and ketamine. J. Appl. Toxicol. 22: 123-128 (2002).
43. A. Benson, A. Sabucedo, J. Almirall, and K.G. Furton. Detection and identification of illicit drugs including GHB, rohypnol, ketamine and psilocybin by refocused solid phase microextraction high performance liquid chromatography mass spectrometry (SPME/HPLC/MS). 223rd ACS National meeting, Orlando, FL, 2002.
44. M.E. Rodriguez Rosas, S. Patel, and I.W. Wainer. Determination of the enantiomers of ketamine and norketamine in human plasma by enantioselective liquid chromatography-mass spectrometry. J. Chromatogr. B 794: 99-108 (2003).
45. D.K. Muge, J.P. Chambers, and A. Livingston. Radioreceptor assay for determination of xylazine and medetomidine in sheep plasma. J. Vet. Pharmacol. Ther. 18: 24-29 (1995).
46. M.E. Gross and N.H. Booth. Tranquilizers, alpha2-adrenergic agonists, and related agents. In Veterinary Pharmacology and Therapeutics, 7th ed., H.R. Adams, Ed. Iowa State University Press, Ames, IA, 1995, ch. 14.
47. H. Kanazawa, Y. Nagata, Y. Matsushima, N. Takai, H. Uchiyama, R. Nishimura, and A. Takeuchi. Liquid chromatography-mass spectrometry for the determination of medetomidine and other anesthetics in plasma. J. Chromatogr. A 631: 215-220 (1993).
48. D.A. Skoog and J.J. Leary. An introduction to chromatographic separations. In Principles of Instrumental Analysis, 4th ed., J. Bortel, C. Field, M.M. Anderson, and A. Potter, Eds. W.W. Saunders Publishing, Orlando, FL, 1992, pp 592-595.
49. S.B. Kastner, P. Wapf, K. Feige, D. Demuth, R. Bettschart-Wolfensberger, M.K. Akens, and M. Huhtinen. Pharmacokinetics and sedative effects of intramuscular medetomidine in domestic sheep. J. Vet. Pharmacol. Ther. 26: 271-276 (2003).
50. E. Kuusela, M. Raekallio, M. Anttila, I. Falck, S. Molsa, and O. Vainio. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J. Vet. Pharmacol. Ther. 23: 15-20 (2000).
51. C.C. Chou, C.L. Chen, B.L. Rice, and P.T. Colahan. Reduced resident time and pharmacodynamic effects of acepromazine after subclinical multiple dosage in exercised thoroughbreds. J. Vet. Pharmacol. Ther. 25: 370-382 (2002).
52. T.A. Bowdle, A.D. Radant, D.S. Cowley, E.D. Kharasch, R.J. Strassman, and P.P. Roy-Byrne. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiol. 88: 82-88 (1998).
53. S. Soback. Xylazine. In Residues of some veterinary drugs in animals and foods. FAO Food and Nutrition Paper (4/19), 1997.
54. K.R. Mama, A.E. Wagner, E.P. Steffey, C. Kollias-Baker, P.W. Hellyer, A.E. Golden, and L.F. Brevard. Clinical responses and plasma drug concentrations associated with different infusions of xylazine and ketamine in horses. Vet. Anaesth. Analges. 27: 54 (2000).
55. J. Idvall, I. Ahlgren, K.R. Aronsen, and P. Stenberg. Ketamine infusions: pharmacokinetics and clinical effects. Br. J. Anaesth. 51: 1167-1173 (1979).